Keeping Track: US FDA's Late Summer Approval Extravaganza Stars Three Novel Agents, Features Return Of Mylotarg

 
• By Bridget Silverman

Kymriah, Vabomere, and benzidazole approvals joined by new indications for Austedo, Faslodex.

Keeping Track Feature image

More from Approvals

More from Product Reviews